Feb 26 (Reuters) - Nanosonics Ltd (NAN) :
- HALF YEAR REVENUE OF A$79.6 MILLION, DOWN 2%
- CONTINUES TO TARGET SUBMISSION OF FDA DE NOVO APPLICATION FOR CORIS BY END OF Q3 FY24
- TOTAL REVENUE IN H2 IS EXPECTED TO GROW BETWEEN 6-15% OVER H1
- HY GROSS PROFIT MARGIN OF 79.7%, UP FROM 78.9% IN PCP
- EXPECT BOTH UNIT AND REVENUE GROWTH IN H2 OVER H1
- FULL YEAR REVENUE IS EXPECTED TO BE BETWEEN A$164 MILLION AND A$171 MILLION
- HY OPERATING PROFIT BEFORE TAX OF A$4.9 MILLION VERSUS A$11.4 MILLION
News: NAN Nanosonics Says FY Revenue Expected Between A$164 Mln And A$171 Mln
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$3.86 |
Change
0.020(0.52%) |
Mkt cap ! $1.172B | |||
| Open | High | Low | Value | Volume |
| $3.83 | $3.89 | $3.75 | $3.924M | 1.020M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4972 | $3.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.90 | 4632 | 2 |
View Market Depth
| Last trade - 16.10pm 10/09/2025 (20 minute delay) ? |
| NAN (ASX) Chart |